N-(4-HYDROXYPHENYL)RETINAMIDE (HPR, FENRETINIDE) INCREASES INTACT APO-RETINOL-BINDING PROTEIN IN RAT-LIVER

被引：0
|
作者：
BOORNAZIAN, ML [1 ]
SMITH, JE [1 ]
机构：
[1] PENN STATE UNIV,DEPT NUTR,UNIV PK,PA 16802
来源：
FASEB JOURNAL | 1993年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A302 / A302
页数：1
相关论文
共 50 条
  • [41] PHASE-II TRIAL OF FENRETINIDE [N-(4-HYDROXYPHENYL) RETINAMIDE] IN MYELODYSPLASIA - POSSIBLE RETINOID-INDUCED DISEASE ACCELERATION
    GAREWAL, HS
    LIST, A
    MEYSKENS, F
    BUZAID, A
    GREENBERG, B
    KATAKKAR, S
    LEUKEMIA RESEARCH, 1989, 13 (04) : 339 - 343
  • [42] Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
    Ohlmann, CH
    Jung, C
    Jaques, G
    INTERNATIONAL JOURNAL OF CANCER, 2002, 100 (05) : 520 - 526
  • [43] Cholecalciferol (Vitamin D-3) and the retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) are synergistic for chemoprevention of prostate cancer
    Tokar, Erik J.
    Ancrile, Brooke B.
    Ablin, Richard J.
    Webber, Mukta M.
    JOURNAL OF EXPERIMENTAL THERAPEUTICS AND ONCOLOGY, 2006, 5 (04) : 323 - 333
  • [44] Increased In Vivo Exposure of N-(4-Hydroxyphenyl) Retinamide (4-HPR) to Achieve Plasma Concentrations Effective against Dengue Virus
    Martin, Alexander J.
    Shackleford, David M.
    Charman, Susan A.
    Wagstaff, Kylie M.
    Porter, Christopher J. H.
    Jans, David A.
    PHARMACEUTICS, 2023, 15 (07)
  • [45] IMPORTANCE OF SYSTEMIC METABOLISM IN THE MODULATION OF SKIN TUMOR-INDUCTION IN MICE BY THE RETINOID N-(4-HYDROXYPHENYL)-RETINAMIDE (4-HPR)
    MCCORMICK, DL
    BAGG, BJ
    HULTIN, TA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 145 - 145
  • [46] N-(4-hydroxyphenyl)retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell lines
    Zou, CP
    Guan, YL
    Zou, CC
    Wang, J
    Wang, LE
    Liebert, M
    Grossman, HB
    Wei, QY
    CANCER LETTERS, 2002, 180 (02) : 131 - 137
  • [47] Antitumor potency and toxicity evaluation of C-linked glucuronides of N-(4-Hydroxyphenyl) retinamide (4-HPR) in mammary cancer
    Curley, Robert W., Jr.
    Alshafie, Galal A.
    Walker, Joel R.
    Nieves, Nirca
    Ahrens, Jamie
    Clagett-Dame, Margaret
    Abou-Issa, Hussein
    CANCER RESEARCH, 2006, 66 (08)
  • [48] Chemotherapeutic evaluation of N-(4-hydroxyphenyl) retinamide-O-glucuronide in the rat mammary tumor model
    AbouIssa, H
    Curley, RW
    Panigot, MJ
    Tanagho, SN
    Sidhu, BS
    Alshafie, GA
    ANTICANCER RESEARCH, 1997, 17 (5A) : 3335 - 3339
  • [49] Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1
    Poliakov, Eugenia
    Samuel, William
    Duncan, Todd
    Gutierrez, Danielle B.
    Mata, Nathan L.
    Redmond, T. Michael
    PLOS ONE, 2017, 12 (04):
  • [50] AN ANTIMETASTATIC EFFECT OF N-(4-HYDROXYPHENYL) RETINAMIDE (4 HPR) ON PROSTATE ADENOCARCINOMA (PA-III) CELLS IN L-W RATS
    POLLARD, M
    LUCKERT, PH
    FASEB JOURNAL, 1991, 5 (05): : A1259 - A1259
12345